GCC - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingGCC: Vaccine Market 2024
Vaccine Market Size in GCC
In 2022, after two years of growth, there was significant decline in the GCC vaccine market, when its value decreased by -44.5% to $X. In general, consumption, however, enjoyed a remarkable increase. As a result, consumption attained the peak level of $X, and then declined dramatically in the following year.
Vaccine Production in GCC
In value terms, vaccine production expanded rapidly to $X in 2022 estimated in export price. Overall, production showed a mild slump. The most prominent rate of growth was recorded in 2014 when the production volume increased by 40%. As a result, production attained the peak level of $X. From 2015 to 2022, production growth failed to regain momentum.
Vaccine Exports
Exports in GCC
In 2022, vaccine exports in GCC expanded markedly to X tons, picking up by 6.3% compared with the previous year's figure. In general, exports, however, saw a drastic downturn. The pace of growth was the most pronounced in 2016 when exports increased by 88%. As a result, the exports attained the peak of X tons. From 2017 to 2022, the growth of the exports remained at a lower figure.
In value terms, vaccine exports surged to $X in 2022. Over the period under review, exports, however, showed a slight contraction. The most prominent rate of growth was recorded in 2020 when exports increased by 133%. The level of export peaked at $X in 2016; however, from 2017 to 2022, the exports failed to regain momentum.
Exports by Country
In 2022, the United Arab Emirates (X tons) represented the key exporter of vaccines for human medicine, achieving 67% of total exports. It was distantly followed by Saudi Arabia (X tons), committing a 31% share of total exports.
Exports from the United Arab Emirates decreased at an average annual rate of -13.7% from 2012 to 2022. Saudi Arabia (-13.0%) illustrated a downward trend over the same period. While the share of Saudi Arabia (+1.6 p.p.) increased significantly in terms of the total exports from 2012-2022, the share of the United Arab Emirates (-2.5 p.p.) displayed negative dynamics.
In value terms, the United Arab Emirates ($X) remains the largest vaccine supplier in GCC, comprising 76% of total exports. The second position in the ranking was held by Saudi Arabia ($X), with a 24% share of total exports.
In the United Arab Emirates, vaccine exports remained relatively stable over the period from 2012-2022.
Export Prices by Country
In 2022, the export price in GCC amounted to $X per ton, picking up by 10% against the previous year. Overall, the export price continues to indicate strong growth. The pace of growth was the most pronounced in 2013 when the export price increased by 116%. Over the period under review, the export prices reached the maximum at $X per ton in 2020; however, from 2021 to 2022, the export prices failed to regain momentum.
Average prices varied somewhat amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while Saudi Arabia stood at $X per ton.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (+15.8%).
Vaccine Imports
Imports in GCC
In 2022, overseas purchases of vaccines for human medicine decreased by -49.5% to X tons for the first time since 2018, thus ending a three-year rising trend. In general, imports, however, saw a strong increase. The most prominent rate of growth was recorded in 2021 with an increase of 349% against the previous year. As a result, imports reached the peak of X tons, and then shrank notably in the following year.
In value terms, vaccine imports shrank sharply to $X in 2022. Over the period under review, imports, however, recorded a significant increase. The most prominent rate of growth was recorded in 2021 when imports increased by 670%. As a result, imports attained the peak of $X, and then declined remarkably in the following year.
Imports by Country
The United Arab Emirates (X tons) and Saudi Arabia (X tons) prevails in imports structure, together committing 88% of total imports. Kuwait (X tons), Oman (X tons) and Qatar (X tons) followed a long way behind the leaders.
From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by the United Arab Emirates (with a CAGR of +28.2%), while imports for the other leaders experienced more modest paces of growth.
In value terms, the United Arab Emirates ($X), Saudi Arabia ($X) and Kuwait ($X) constituted the countries with the highest levels of imports in 2022, together comprising 92% of total imports.
In terms of the main importing countries, the United Arab Emirates, with a CAGR of +33.9%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
The import price in GCC stood at $X per ton in 2022, rising by 12% against the previous year. Overall, the import price saw strong growth. The pace of growth was the most pronounced in 2021 when the import price increased by 72%. The level of import peaked in 2022 and is likely to see gradual growth in years to come.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Qatar ($X per ton), while Oman ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Qatar (+38.6%), while the other leaders experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the vaccine market in GCC. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in GCC, split by region and country
- Trade (exports and imports) in GCC
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the vaccine market in Asia.
This report provides an in-depth analysis of the vaccine market in the U.S..
This report provides an in-depth analysis of the vaccine market in China.
This report provides an in-depth analysis of the vaccine market in the EU.
This report provides an in-depth analysis of the global vaccine market.